Pearlify UI

Pearlify Data Viewer

read-only

홈 · 표

재무제표 주요계정

보고서별 핵심 계정(매출·이익·자산 등). 계정명은 공시 원문 그대로, 지표는 규칙으로 매핑합니다.

기술 정보 숨기기
ID수집원원본 키발생값 ↓시간 정밀도시간 의미관측 가능 시각적재일시원본 레코드파서 버전원시 식별자법인DART 코드회사명사업연도기간연결구분재무제표계정명표준 지표금액통화기준일접수번호
cmrxew0th01rj0zgwbog13dsrdart-financials00382199:2025:11014:CFS:IS:영업이익(손실)2025-11-14dayevent2026-07-23 20:12:052026-07-23 20:12:05cmrxew0qn01r20zgwgse1jfz41
{ "value": "00382199", "scheme": "corp_code" }
{
  "value": "00382199",
  "scheme": "corp_code"
}
—00382199신한지주2,025Q3CFSIS영업이익(손실)—1.9조원KRW2025-09-3020251114002208
cmrxew0tn01rk0zgw2xjpuqzpdart-financials00382199:2025:11014:CFS:IS:총포괄손익2025-11-14dayevent2026-07-23 20:12:052026-07-23 20:12:05cmrxew0qn01r20zgwgse1jfz41
{ "value": "00382199", "scheme": "corp_code" }
{
  "value": "00382199",
  "scheme": "corp_code"
}
—00382199신한지주2,025Q3CFSIS총포괄손익comprehensive_income1.3조원KRW2025-09-3020251114002208
cmrxew0tu01rl0zgw0tnc4ykudart-financials00382199:2025:11014:CFS:IS:순수수료손익2025-11-14dayevent2026-07-23 20:12:052026-07-23 20:12:05cmrxew0qn01r20zgwgse1jfz41
{ "value": "00382199", "scheme": "corp_code" }
{
  "value": "00382199",
  "scheme": "corp_code"
}
—00382199신한지주2,025Q3CFSIS순수수료손익—7680.6억원KRW2025-09-3020251114002208
cmrxew0u001rm0zgwyxlvldy3dart-financials00382199:2025:11014:OFS:BS:자산총계2025-11-14dayevent2026-07-23 20:12:052026-07-23 20:12:05cmrxew0qn01r20zgwgse1jfz41
{ "value": "00382199", "scheme": "corp_code" }
{
  "value": "00382199",
  "scheme": "corp_code"
}
—00382199신한지주2,025Q3OFSBS자산총계total_assets38.4조원KRW2025-09-3020251114002208
cmrxew0u601rn0zgwpm6pz0jadart-financials00382199:2025:11014:OFS:BS:부채총계2025-11-14dayevent2026-07-23 20:12:052026-07-23 20:12:05cmrxew0qn01r20zgwgse1jfz41
{ "value": "00382199", "scheme": "corp_code" }
{
  "value": "00382199",
  "scheme": "corp_code"
}
—00382199신한지주2,025Q3OFSBS부채총계total_liabilities11.3조원KRW2025-09-3020251114002208
cmrxew0uc01ro0zgwh2ecqnbxdart-financials00382199:2025:11014:OFS:BS:자본금2025-11-14dayevent2026-07-23 20:12:052026-07-23 20:12:05cmrxew0qn01r20zgwgse1jfz41
{ "value": "00382199", "scheme": "corp_code" }
{
  "value": "00382199",
  "scheme": "corp_code"
}
—00382199신한지주2,025Q3OFSBS자본금capital_stock2.9조원KRW2025-09-3020251114002208
cmrxew0ui01rp0zgw6uqvw5t2dart-financials00382199:2025:11014:OFS:BS:이익잉여금2025-11-14dayevent2026-07-23 20:12:052026-07-23 20:12:05cmrxew0qn01r20zgwgse1jfz41
{ "value": "00382199", "scheme": "corp_code" }
{
  "value": "00382199",
  "scheme": "corp_code"
}
—00382199신한지주2,025Q3OFSBS이익잉여금retained_earnings8.2조원KRW2025-09-3020251114002208
cmrxew0uo01rq0zgwv33t37v0dart-financials00382199:2025:11014:OFS:BS:자본총계2025-11-14dayevent2026-07-23 20:12:052026-07-23 20:12:05cmrxew0qn01r20zgwgse1jfz41
{ "value": "00382199", "scheme": "corp_code" }
{
  "value": "00382199",
  "scheme": "corp_code"
}
—00382199신한지주2,025Q3OFSBS자본총계total_equity27조원KRW2025-09-3020251114002208
cmrxew0uu01rr0zgwj2qao1uhdart-financials00382199:2025:11014:OFS:IS:법인세차감전 순이익2025-11-14dayevent2026-07-23 20:12:052026-07-23 20:12:05cmrxew0qn01r20zgwgse1jfz41
{ "value": "00382199", "scheme": "corp_code" }
{
  "value": "00382199",
  "scheme": "corp_code"
}
—00382199신한지주2,025Q3OFSIS법인세차감전 순이익pretax_income-470.7억원KRW2025-09-3020251114002208
cmrxew0v001rs0zgw3do2snc6dart-financials00382199:2025:11014:OFS:IS:당기순이익(손실)2025-11-14dayevent2026-07-23 20:12:052026-07-23 20:12:05cmrxew0qn01r20zgwgse1jfz41
{ "value": "00382199", "scheme": "corp_code" }
{
  "value": "00382199",
  "scheme": "corp_code"
}
—00382199신한지주2,025Q3OFSIS당기순이익(손실)net_income-214.1억원KRW2025-09-3020251114002208
cmrxew0v701rt0zgwy4paf5yydart-financials00382199:2025:11014:OFS:BS:당기손익-공정가치측정금융자산2025-11-14dayevent2026-07-23 20:12:052026-07-23 20:12:05cmrxew0qn01r20zgwgse1jfz41
{ "value": "00382199", "scheme": "corp_code" }
{
  "value": "00382199",
  "scheme": "corp_code"
}
—00382199신한지주2,025Q3OFSBS당기손익-공정가치측정금융자산—3.5조원KRW2025-09-3020251114002208
cmrxew0vd01ru0zgwxyju1lp9dart-financials00382199:2025:11014:OFS:IS:순이자손익2025-11-14dayevent2026-07-23 20:12:052026-07-23 20:12:05cmrxew0qn01r20zgwgse1jfz41
{ "value": "00382199", "scheme": "corp_code" }
{
  "value": "00382199",
  "scheme": "corp_code"
}
—00382199신한지주2,025Q3OFSIS순이자손익—-612.5억원KRW2025-09-3020251114002208
cmrxew0vj01rv0zgwk67ty0xhdart-financials00382199:2025:11014:OFS:IS:이자수익2025-11-14dayevent2026-07-23 20:12:052026-07-23 20:12:05cmrxew0qn01r20zgwgse1jfz41
{ "value": "00382199", "scheme": "corp_code" }
{
  "value": "00382199",
  "scheme": "corp_code"
}
—00382199신한지주2,025Q3OFSIS이자수익—237.3억원KRW2025-09-3020251114002208
cmrxew0vp01rw0zgwljn268brdart-financials00382199:2025:11014:OFS:IS:이자비용2025-11-14dayevent2026-07-23 20:12:052026-07-23 20:12:05cmrxew0qn01r20zgwgse1jfz41
{ "value": "00382199", "scheme": "corp_code" }
{
  "value": "00382199",
  "scheme": "corp_code"
}
—00382199신한지주2,025Q3OFSIS이자비용—849.8억원KRW2025-09-3020251114002208
cmrxew0vw01rx0zgw2sezc8zqdart-financials00382199:2025:11014:OFS:IS:영업이익(손실)2025-11-14dayevent2026-07-23 20:12:052026-07-23 20:12:05cmrxew0qn01r20zgwgse1jfz41
{ "value": "00382199", "scheme": "corp_code" }
{
  "value": "00382199",
  "scheme": "corp_code"
}
—00382199신한지주2,025Q3OFSIS영업이익(손실)—-467.1억원KRW2025-09-3020251114002208
cmrxew0w201ry0zgw9f6y0qggdart-financials00382199:2025:11014:OFS:IS:총포괄손익2025-11-14dayevent2026-07-23 20:12:052026-07-23 20:12:05cmrxew0qn01r20zgwgse1jfz41
{ "value": "00382199", "scheme": "corp_code" }
{
  "value": "00382199",
  "scheme": "corp_code"
}
—00382199신한지주2,025Q3OFSIS총포괄손익comprehensive_income-214.1억원KRW2025-09-3020251114002208
cmrxew0w901rz0zgw33jgvstbdart-financials00382199:2025:11014:OFS:IS:순수수료손익2025-11-14dayevent2026-07-23 20:12:052026-07-23 20:12:05cmrxew0qn01r20zgwgse1jfz41
{ "value": "00382199", "scheme": "corp_code" }
{
  "value": "00382199",
  "scheme": "corp_code"
}
—00382199신한지주2,025Q3OFSIS순수수료손익—176.4억원KRW2025-09-3020251114002208
cmrxew1ji01vj0zgwic6539yedart-financials00877059:2025:11014:CFS:BS:유동자산2025-11-14dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1jd01vi0zgw8hi8xqv71
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q3CFSBS유동자산current_assets6.3조원KRW2025-09-3020251114001632
cmrxew1jn01vk0zgw44p4q0otdart-financials00877059:2025:11014:CFS:BS:비유동자산2025-11-14dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1jd01vi0zgw8hi8xqv71
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q3CFSBS비유동자산non_current_assets11.9조원KRW2025-09-3020251114001632
cmrxew1jt01vl0zgwn17w7hcndart-financials00877059:2025:11014:CFS:BS:자산총계2025-11-14dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1jd01vi0zgw8hi8xqv71
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q3CFSBS자산총계total_assets18.3조원KRW2025-09-3020251114001632
cmrxew1jz01vm0zgwmwicsj53dart-financials00877059:2025:11014:CFS:BS:유동부채2025-11-14dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1jd01vi0zgw8hi8xqv71
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q3CFSBS유동부채current_liabilities3.7조원KRW2025-09-3020251114001632
cmrxew1k501vn0zgwy52x3odadart-financials00877059:2025:11014:CFS:BS:비유동부채2025-11-14dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1jd01vi0zgw8hi8xqv71
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q3CFSBS비유동부채non_current_liabilities2.3조원KRW2025-09-3020251114001632
cmrxew1kb01vo0zgwalk20ol9dart-financials00877059:2025:11014:CFS:BS:부채총계2025-11-14dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1jd01vi0zgw8hi8xqv71
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q3CFSBS부채총계total_liabilities6.1조원KRW2025-09-3020251114001632
cmrxew1kh01vp0zgwsw6b8g5ndart-financials00877059:2025:11014:CFS:BS:자본금2025-11-14dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1jd01vi0zgw8hi8xqv71
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q3CFSBS자본금capital_stock1779.3억원KRW2025-09-3020251114001632
cmrxew1kn01vq0zgw9wv5cym8dart-financials00877059:2025:11014:CFS:BS:이익잉여금2025-11-14dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1jd01vi0zgw8hi8xqv71
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q3CFSBS이익잉여금retained_earnings6.3조원KRW2025-09-3020251114001632
cmrxew1ku01vr0zgwatb36wv3dart-financials00877059:2025:11014:CFS:BS:자본총계2025-11-14dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1jd01vi0zgw8hi8xqv71
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q3CFSBS자본총계total_equity12.1조원KRW2025-09-3020251114001632
cmrxew1l001vs0zgwl81fwktpdart-financials00877059:2025:11014:CFS:IS:매출액2025-11-14dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1jd01vi0zgw8hi8xqv71
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q3CFSIS매출액revenue1.6조원KRW2025-09-3020251114001632
cmrxew1l601vt0zgwusn1nfmsdart-financials00877059:2025:11014:CFS:IS:영업이익2025-11-14dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1jd01vi0zgw8hi8xqv71
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q3CFSIS영업이익operating_income7288.4억원KRW2025-09-3020251114001632
cmrxew1lc01vu0zgwmehiouxzdart-financials00877059:2025:11014:CFS:IS:법인세차감전 순이익2025-11-14dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1jd01vi0zgw8hi8xqv71
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q3CFSIS법인세차감전 순이익pretax_income7670억원KRW2025-09-3020251114001632
cmrxew1li01vv0zgwp9mu8w6ldart-financials00877059:2025:11014:CFS:IS:당기순이익(손실)2025-11-14dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1jd01vi0zgw8hi8xqv71
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q3CFSIS당기순이익(손실)net_income5744.5억원KRW2025-09-3020251114001632
cmrxew1lo01vw0zgw3t6c2qwmdart-financials00877059:2025:11014:CFS:IS:총포괄손익2025-11-14dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1jd01vi0zgw8hi8xqv71
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q3CFSIS총포괄손익comprehensive_income5766.2억원KRW2025-09-3020251114001632
cmrxew1lu01vx0zgw6iybzrmbdart-financials00877059:2025:11014:OFS:BS:유동자산2025-11-14dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1jd01vi0zgw8hi8xqv71
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q3OFSBS유동자산current_assets4.7조원KRW2025-09-3020251114001632
cmrxew1m001vy0zgw0ki9qkprdart-financials00877059:2025:11014:OFS:BS:비유동자산2025-11-14dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1jd01vi0zgw8hi8xqv71
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q3OFSBS비유동자산non_current_assets9.6조원KRW2025-09-3020251114001632
cmrxew1m601vz0zgwfzhofxcfdart-financials00877059:2025:11014:OFS:BS:자산총계2025-11-14dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1jd01vi0zgw8hi8xqv71
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q3OFSBS자산총계total_assets14.4조원KRW2025-09-3020251114001632
cmrxew1mc01w00zgwx7gwad09dart-financials00877059:2025:11014:OFS:BS:유동부채2025-11-14dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1jd01vi0zgw8hi8xqv71
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q3OFSBS유동부채current_liabilities2.7조원KRW2025-09-3020251114001632
cmrxew1mh01w10zgwo9qthe85dart-financials00877059:2025:11014:OFS:BS:비유동부채2025-11-14dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1jd01vi0zgw8hi8xqv71
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q3OFSBS비유동부채non_current_liabilities1.2조원KRW2025-09-3020251114001632
cmrxew1mn01w20zgwxz15rpbhdart-financials00877059:2025:11014:OFS:BS:부채총계2025-11-14dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1jd01vi0zgw8hi8xqv71
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q3OFSBS부채총계total_liabilities4조원KRW2025-09-3020251114001632
cmrxew1mu01w30zgw7hdwfiq7dart-financials00877059:2025:11014:OFS:BS:자본금2025-11-14dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1jd01vi0zgw8hi8xqv71
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q3OFSBS자본금capital_stock1779.3억원KRW2025-09-3020251114001632
cmrxew1n001w40zgwbk7tgc3odart-financials00877059:2025:11014:OFS:BS:이익잉여금2025-11-14dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1jd01vi0zgw8hi8xqv71
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q3OFSBS이익잉여금retained_earnings4.5조원KRW2025-09-3020251114001632
cmrxew1n601w50zgw684j9x2vdart-financials00877059:2025:11014:OFS:BS:자본총계2025-11-14dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1jd01vi0zgw8hi8xqv71
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q3OFSBS자본총계total_equity10.4조원KRW2025-09-3020251114001632
cmrxew1nc01w60zgwsnxks3andart-financials00877059:2025:11014:OFS:IS:매출액2025-11-14dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1jd01vi0zgw8hi8xqv71
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q3OFSIS매출액revenue1.2조원KRW2025-09-3020251114001632
cmrxew1ni01w70zgwr7xw7k7ddart-financials00877059:2025:11014:OFS:IS:영업이익2025-11-14dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1jd01vi0zgw8hi8xqv71
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q3OFSIS영업이익operating_income6332.6억원KRW2025-09-3020251114001632
cmrxew1no01w80zgwe7m8gzywdart-financials00877059:2025:11014:OFS:IS:법인세차감전 순이익2025-11-14dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1jd01vi0zgw8hi8xqv71
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q3OFSIS법인세차감전 순이익pretax_income6627.4억원KRW2025-09-3020251114001632
cmrxew1nv01w90zgwfs4l0elpdart-financials00877059:2025:11014:OFS:IS:당기순이익(손실)2025-11-14dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1jd01vi0zgw8hi8xqv71
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q3OFSIS당기순이익(손실)net_income4964.7억원KRW2025-09-3020251114001632
cmrxew1o101wa0zgwsp451lradart-financials00877059:2025:11014:OFS:IS:총포괄손익2025-11-14dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1jd01vi0zgw8hi8xqv71
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q3OFSIS총포괄손익comprehensive_income4959.5억원KRW2025-09-3020251114001632
cmrxew2a601zt0zgw94bopwy1dart-financials01515323:2025:11014:CFS:IS:매출액2025-11-14dayevent2026-07-23 20:12:072026-07-23 20:12:07cmrxew28k01zj0zgwijh0gcm31
{ "value": "01515323", "scheme": "corp_code" }
{
  "value": "01515323",
  "scheme": "corp_code"
}
—01515323LG에너지솔루션2,025Q3CFSIS매출액revenue5.6조원KRW2025-09-3020251114000625
cmrxew28o01zk0zgw8l9cdxxmdart-financials01515323:2025:11014:CFS:BS:유동자산2025-11-14dayevent2026-07-23 20:12:072026-07-23 20:12:07cmrxew28k01zj0zgwijh0gcm31
{ "value": "01515323", "scheme": "corp_code" }
{
  "value": "01515323",
  "scheme": "corp_code"
}
—01515323LG에너지솔루션2,025Q3CFSBS유동자산current_assets17.1조원KRW2025-09-3020251114000625
cmrxew28u01zl0zgwqoublho3dart-financials01515323:2025:11014:CFS:BS:비유동자산2025-11-14dayevent2026-07-23 20:12:072026-07-23 20:12:07cmrxew28k01zj0zgwijh0gcm31
{ "value": "01515323", "scheme": "corp_code" }
{
  "value": "01515323",
  "scheme": "corp_code"
}
—01515323LG에너지솔루션2,025Q3CFSBS비유동자산non_current_assets49.8조원KRW2025-09-3020251114000625
cmrxew29001zm0zgw88ap007ndart-financials01515323:2025:11014:CFS:BS:자산총계2025-11-14dayevent2026-07-23 20:12:072026-07-23 20:12:07cmrxew28k01zj0zgwijh0gcm31
{ "value": "01515323", "scheme": "corp_code" }
{
  "value": "01515323",
  "scheme": "corp_code"
}
—01515323LG에너지솔루션2,025Q3CFSBS자산총계total_assets67조원KRW2025-09-3020251114000625
cmrxew29601zn0zgwqsxenedqdart-financials01515323:2025:11014:CFS:BS:유동부채2025-11-14dayevent2026-07-23 20:12:072026-07-23 20:12:07cmrxew28k01zj0zgwijh0gcm31
{ "value": "01515323", "scheme": "corp_code" }
{
  "value": "01515323",
  "scheme": "corp_code"
}
—01515323LG에너지솔루션2,025Q3CFSBS유동부채current_liabilities16.2조원KRW2025-09-3020251114000625
4,008건 중 2,401–2,450← 이전49 / 81 쪽다음 →

fundamental_facts · 컬럼 24개 · occurredAt desc 정렬